Related Experiment Video
Updated: Apr 21, 2026

Author Spotlight: Quantitative Assessment of 8-oxo-dG in MCF-7 Cells Using ELISA
Published on: May 24, 2024
Apigenin induced MCF-7 cell apoptosis-associated reactive oxygen species
Haihua Bai1, Hua Jin, Fen Yang
1Department of Chemistry and Institute for Nano-Chemistry, Jinan University, Guangzhou, China.
Abstract:
Apigenin is a flavonoid, which has been proved to possess effective anti-cancer bioactivities against variety of cell lines. However, little is known about its effect on the cell-surface and the interaction between cell-surface and the reacting drug. In this study, human breast cancer line (MCF-7) was selected to be as a cell model to investigate the effects of apigenin on cell growth, proliferation, apoptosis, cellular morphology, etc. MTT assay showed that the growth inhibition induced by apigenin was in a dose-dependent manner when treated with different concentrations of apigenin while had little cytotoxic effects on human normal cells (MCF-10A). Fluorescence-based flow cytometry was used to detect cellular apoptosis and ROS production. The results showed that 80 µM apigenin could effectively induce apoptosis and overproduction of ROS in MCF-7 cells. Here, atomic force microscopy (AFM) was utilized to detect the shapes and membrane structures of MCF-7 cells at cellular or subcellular level. The results showed that the control MCF-7 cells presented typical elongated-spindle shapes with abundant pseudopodia, while after treated with apigenin, the cells shrunk and became round, the pseudopodia diminished. Moreover, the images of ultrastructure indicated that the cell membrane was composed of nanoparticles of 49 nm, but with the treated concentrations of apigenin increasing, the sizes of membrane particles significantly increased to 400 nm. These results can improve our understanding of apigenin, which can be potentially developed as a new agent for treatment of cancers.
Insights
Apigenin, a flavonoid, effectively inhibits breast cancer cell growth and induces apoptosis by increasing ROS production. It alters cell morphology and significantly increases the size of cell membrane nanoparticles.
Area of Science:
- Biochemistry
- Cell Biology
- Materials Science
Background:
- Flavonoids, including apigenin, exhibit potent anti-cancer properties.
- The effects of apigenin on cancer cell surface characteristics and drug interactions remain underexplored.
Purpose of the Study:
- To investigate apigenin's impact on human breast cancer cells (MCF-7), focusing on cell surface and membrane structure.
- To evaluate apigenin's efficacy in inhibiting cancer cell growth, inducing apoptosis, and altering cellular morphology.
Main Methods:
- MTT assay for cell growth inhibition and cytotoxicity.
- Flow cytometry for assessing apoptosis and reactive oxygen species (ROS) production.
- Atomic Force Microscopy (AFM) for analyzing cell and membrane ultrastructure.
Main Results:
- Apigenin demonstrated dose-dependent growth inhibition in MCF-7 cells with minimal toxicity to normal MCF-10A cells.
- Apigenin (80 µM) induced significant apoptosis and ROS overproduction in MCF-7 cells.
- AFM revealed apigenin treatment caused MCF-7 cells to shrink and round, diminishing pseudopodia and increasing cell membrane nanoparticle size from 49 nm to 400 nm.
Conclusions:
- Apigenin effectively inhibits breast cancer cell growth and induces apoptosis.
- Apigenin alters MCF-7 cell morphology and significantly impacts cell membrane structure.
- Apigenin shows potential as a novel therapeutic agent for cancer treatment.
Related Concept Videos
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway

